Lung Neoplasms  >>  Mekinist (trametinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mekinist (trametinib) / Novartis, BeiGene
NCT01362296: An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Checkmark WCLC 2013
Oct 2013 - Oct 2013: WCLC 2013
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
134
US, Europe, RoW
GSK1120212, docetaxel
GlaxoSmithKline
Lung Cancer, Non-Small Cell
09/12
09/13

Download Options